↓ Skip to main content

Infliximab as rescue therapy in hospitalised patients with steroid‐refractory acute ulcerative colitis: a long‐term follow‐up of 211 Swedish patients

Overview of attention for article published in Alimentary Pharmacology & Therapeutics, June 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

policy
1 policy source
twitter
3 X users
facebook
1 Facebook page

Readers on

mendeley
96 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Infliximab as rescue therapy in hospitalised patients with steroid‐refractory acute ulcerative colitis: a long‐term follow‐up of 211 Swedish patients
Published in
Alimentary Pharmacology & Therapeutics, June 2013
DOI 10.1111/apt.12387
Pubmed ID
Authors

M. Sjöberg, A. Magnuson, J. Björk, C. Benoni, S. Almer, I. Friis‐Liby, E. Hertervig, M. Olsson, P. Karlén, A. Eriksson, G. Midhagen, M. Carlson, A. Lapidus, J. Halfvarson, C. Tysk, Swedish Organization for the Study of Inflammatory Bowel Disease

Abstract

Rescue therapy with infliximab (IFX) has been proven effective in a steroid-refractory attack of ulcerative colitis (UC). The long-term efficacy is not well described.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 4 4%
Spain 1 1%
Brazil 1 1%
Unknown 90 94%

Demographic breakdown

Readers by professional status Count As %
Professor > Associate Professor 12 13%
Student > Postgraduate 11 11%
Researcher 10 10%
Student > Master 10 10%
Other 8 8%
Other 30 31%
Unknown 15 16%
Readers by discipline Count As %
Medicine and Dentistry 62 65%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Computer Science 3 3%
Agricultural and Biological Sciences 2 2%
Engineering 2 2%
Other 7 7%
Unknown 17 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 April 2021.
All research outputs
#6,572,065
of 25,374,647 outputs
Outputs from Alimentary Pharmacology & Therapeutics
#2,252
of 5,634 outputs
Outputs of similar age
#52,453
of 208,946 outputs
Outputs of similar age from Alimentary Pharmacology & Therapeutics
#26
of 62 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 5,634 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.9. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 208,946 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.